Hospital
The Ingalls Memorial Hospital
The Ingalls Memorial Hospital was paid $1.30M by Medicaid between Jan 2018 and Jun 2020, across 66 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 78% of everything it billed.
33Billing provider infoTHE INGALLS MEMORIAL HOSPITAL
HARVEY, IL 60426
HARVEY, IL 60426
33aNPI1821185364assigned 10/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.30M
24GClaims34,395
24DCodes billed66
24AFirst – last monthJan 2018 – Jun 2020
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#42 of 129
Median peer was paid$547K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,213 | $355K | |
| 2019 | 12,653 | $522K | |
| 2020 | 10,529 | $422K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 78% | 9,379 | 1,781 | $1.01M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5.2% | 1,274 | 1,165 | $68K |
| 97162 | 5.1% | 603 | 484 | $66K | |
| 97161 | 1.6% | 199 | 147 | $20K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 69 | 36 | $11K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,023 | 848 | $11K |
| 80053 | Comprehensive metabolic panel | <1% | 2,340 | 1,776 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 377 | 349 | $10K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 304 | 245 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 930 | 734 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 916 | 794 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 788 | 634 | $7K |
54 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 153 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,432 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,966 | $4K |
| 80061 | Lipid panel | <1% | 1,282 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 759 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 153 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 152 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 622 | $3K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 92 | $3K |
| 85027 | <1% | 967 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 778 | $2K |
| 84439 | <1% | 419 | $2K | |
| 80050 | General health panel | <1% | 206 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 342 | $2K |
| 72110 | <1% | 72 | $1K | |
| 87581 | <1% | 71 | $1K | |
| 85610 | <1% | 684 | $1K | |
| 87486 | <1% | 71 | $1K | |
| 82607 | <1% | 206 | $1K | |
| 81001 | <1% | 668 | $773.34 | |
| 73564 | <1% | 54 | $614.52 | |
| 82570 | <1% | 267 | $586.82 | |
| 84702 | <1% | 129 | $559.47 | |
| 86592 | <1% | 319 | $500.91 | |
| 81003 | <1% | 558 | $488.41 | |
| 73630 | <1% | 44 | $470.70 | |
| 80081 | <1% | 15 | $360.44 | |
| 83655 | <1% | 68 | $319.91 | |
| 73610 | <1% | 16 | $300.20 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 19 | $223.53 |
| 82728 | <1% | 74 | $219.66 | |
| 81025 | <1% | 180 | $214.86 | |
| 82043 | <1% | 120 | $213.79 | |
| 85018 | <1% | 192 | $161.60 | |
| 85014 | <1% | 191 | $151.43 | |
| 84146 | <1% | 15 | $130.60 | |
| 83735 | <1% | 50 | $125.49 | |
| 84703 | <1% | 45 | $115.45 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 21 | $114.86 |
| 83540 | <1% | 34 | $99.22 | |
| 86850 | <1% | 44 | $99.19 | |
| 85652 | <1% | 119 | $95.92 | |
| 83550 | <1% | 27 | $95.68 | |
| 87070 | <1% | 21 | $84.62 | |
| 86901 | <1% | 50 | $82.83 | |
| 82950 | <1% | 26 | $75.21 | |
| 73130 | <1% | 12 | $66.77 | |
| 86900 | <1% | 50 | $59.83 | |
| 82746 | <1% | 12 | $50.21 | |
| 87205 | <1% | 35 | $49.45 | |
| 86140 | <1% | 36 | $41.34 | |
| 85660 | <1% | 13 | $18.28 | |
| 84550 | <1% | 17 | $17.26 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 225 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRYOR, VINCENT (CHIEF FINANCIAL OFFICER AND CORP VP)